SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '9VE'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UHO_A_VDNA1000_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	6 / 10	TYR A 405 HIS A 406 PHE A 586 GLN A 615 GLY A 617 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) None 9VE A 801 (-3.9A)	0.34A	1uhoA-5ohjA: 36.4	1uhoA-5ohjA: 12.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	HIS A 446 MET A 519 THR A 579 GLN A 615 PHE A 618	ZN A 699 (-3.2A) 9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	1.43A	1xlxA-5ohjA: 52.6	1xlxA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	12 / 12	TYR A 405 HIS A 406 HIS A 450 MET A 519 LEU A 565 ASN A 567 THR A 579 ILE A 582 MET A 583 SER A 614 GLN A 615 PHE A 618	None None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.36A	1xlxA-5ohjA: 52.6	1xlxA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	8 / 12	HIS A 406 HIS A 450 MET A 519 MET A 583 PHE A 586 MET A 603 SER A 614 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.94A	1xlxB-5ohjA: 52.6	1xlxB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	HIS A 446 MET A 519 THR A 579 GLN A 615 PHE A 618	ZN A 699 (-3.2A) 9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	1.44A	1xlxB-5ohjA: 52.6	1xlxB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 HIS A 450 MET A 519 THR A 579 ILE A 582 MET A 583 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None None 9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.62A	1xlxB-5ohjA: 52.6	1xlxB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 ASP A 564 LEU A 565 PRO A 568 TYR A 575 TRP A 578 ILE A 582 PHE A 586 SER A 614 PHE A 618	None None ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.26A	1xmuA-5ohjA: 53.3	1xmuA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	8 / 12	TYR A 405 LEU A 565 PRO A 568 TYR A 575 TRP A 578 ILE A 582 MET A 603 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.67A	1xmuA-5ohjA: 53.3	1xmuA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 5	MET A 519 ASN A 567 THR A 579 MET A 583 GLN A 615	9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.2A)	0.28A	1xmuA-5ohjA: 53.3	1xmuA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 PRO A 568 TYR A 575 TRP A 578 ILE A 582 PHE A 586 SER A 614	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A)	0.30A	1xmuB-5ohjA: 52.8	1xmuB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	10 / 12	TYR A 405 MET A 519 ASP A 564 LEU A 565 PRO A 568 TYR A 575 TRP A 578 ILE A 582 MET A 603 SER A 614	None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A)	0.65A	1xmuB-5ohjA: 52.8	1xmuB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 5	ASN A 567 THR A 579 MET A 583 GLN A 615 PHE A 618	9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.15A	1xmuB-5ohjA: 52.8	1xmuB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	6 / 12	TYR A 405 ASP A 447 ILE A 582 MET A 583 PHE A 586 MET A 603	None MG A 700 ( 2.7A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A)	1.41A	1xomA-5ohjA: 52.6	1xomA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 ILE A 582 MET A 583 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.59A	1xomA-5ohjA: 52.6	1xomA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 ILE A 582 MET A 583 PHE A 586 SER A 614 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.27A	1xomA-5ohjA: 52.6	1xomA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 THR A 579 ILE A 582 MET A 583 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.58A	1xomB-5ohjA: 52.1	1xomB-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 THR A 579 ILE A 582 MET A 583 PHE A 586 SER A 614 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.29A	1xomB-5ohjA: 52.1	1xomB-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 12	TYR A 405 HIS A 410 MET A 519 LEU A 565 THR A 579 GLN A 615 PHE A 618	None ZN A 699 (-3.3A) 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	1.47A	1xomB-5ohjA: 52.1	1xomB-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 PRO A 568 TYR A 575 THR A 579 ILE A 582 SER A 614 PHE A 618	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.25A	1xoqA-5ohjA: 52.6	1xoqA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 LEU A 565 PRO A 568 TYR A 575 THR A 579 ILE A 582 MET A 603 SER A 614 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.56A	1xoqA-5ohjA: 52.6	1xoqA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	3 / 3	ASN A 567 TRP A 578 GLN A 615	9VE A 801 (-4.1A) None 9VE A 801 (-3.2A)	0.10A	1xoqA-5ohjA: 52.6	1xoqA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 ASP A 564 LEU A 565 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 SER A 614 PHE A 618	None None ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.15A	1xoqB-5ohjA: 51.9	1xoqB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 LEU A 565 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 MET A 603 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.55A	1xoqB-5ohjA: 51.9	1xoqB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	3 / 3	MET A 519 ASN A 567 GLN A 615	9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-3.2A)	0.31A	1xoqB-5ohjA: 51.9	1xoqB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 MET A 583 PHE A 586 MET A 603 GLN A 615 PHE A 618 ILE A 622	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A) 9VE A 801 (-4.8A)	0.61A	1xosA-5ohjA: 52.1	1xosA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 MET A 583 PHE A 586 SER A 601	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) None	1.21A	1xosA-5ohjA: 52.1	1xosA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 12	TYR A 405 HIS A 410 MET A 519 LEU A 565 GLN A 615 PHE A 618 ILE A 622	None ZN A 699 (-3.3A) 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A) 9VE A 801 (-4.8A)	1.46A	1xosA-5ohjA: 52.1	1xosA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	12 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 ILE A 582 MET A 583 SER A 601 MET A 603 SER A 614 GLN A 615 PHE A 618 ILE A 622	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) None 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A) 9VE A 801 (-4.8A)	0.92A	1xotA-5ohjA: 52.6	1xotA-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	8 / 12	HIS A 406 MET A 519 LEU A 565 MET A 583 SER A 601 MET A 603 SER A 614 PHE A 618	None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 ( 4.0A) None 9VE A 801 (-3.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.91A	1xotB-5ohjA: 52.6	1xotB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 ASN A 567 ILE A 582 MET A 583 SER A 601 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.64A	1xotB-5ohjA: 52.6	1xotB-5ohjA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	TYR A 405 HIS A 406 PHE A 586 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.37A	2h42A-5ohjA: 36.2	2h42A-5ohjA: 13.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	TYR A 405 LEU A 565 PHE A 586 GLN A 615 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.56A	2h42C-5ohjA: 35.9	2h42C-5ohjA: 13.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 HIS A 406 LEU A 565 ILE A 582 GLU A 585 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) None 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	1.04A	2weyA-5ohjA: 37.9	2weyA-5ohjA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_A_VDNA1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	6 / 12	TYR A 405 HIS A 406 LEU A 565 PHE A 586 GLN A 615 PHE A 618	None None 9VE A 801 (-4.7A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.68A	3b2rA-5ohjA: 31.5	3b2rA-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_B_VDNB1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	TYR A 405 HIS A 406 LEU A 565 GLN A 615 PHE A 618	None None 9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.69A	3b2rB-5ohjA: 31.5	3b2rB-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CZV_A_AZMA263_1 (CARBONIC ANHYDRASE 13)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	HIS A 410 HIS A 446 PHE A 618 THR A 517 VAL A 623	ZN A 699 (-3.3A) ZN A 699 (-3.2A) 9VE A 801 (-3.9A) None None	1.11A	3czvA-5ohjA: undetectable 3czvB-5ohjA: undetectable	3czvA-5ohjA: 14.92 3czvB-5ohjA: 14.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 ASN A 567 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 MET A 603 PHE A 618	None 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.68A	3g4lA-5ohjA: 51.7	3g4lA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASN A 567 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 SER A 614 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A)	0.27A	3g4lA-5ohjA: 51.7	3g4lA-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 PRO A 568 TRP A 578 THR A 579 ILE A 582 MET A 583 PHE A 618	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.9A)	0.26A	3g4lB-5ohjA: 52.0	3g4lB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 LEU A 565 PRO A 568 TRP A 578 THR A 579 ILE A 582 MET A 583 MET A 603 PHE A 618	None None 9VE A 801 (-3.8A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.52A	3g4lB-5ohjA: 52.0	3g4lB-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	11 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 ASN A 567 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A)	0.26A	3g4lC-5ohjA: 52.1	3g4lC-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 12	TYR A 405 LEU A 565 ASN A 567 PRO A 568 TYR A 575 TRP A 578 THR A 579 ILE A 582 MET A 603	None 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.6A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A)	0.55A	3g4lC-5ohjA: 52.1	3g4lC-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	3 / 3	SER A 614 GLN A 615 PHE A 618	9VE A 801 (-4.7A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.18A	3g4lC-5ohjA: 52.1	3g4lC-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	12 / 12	TYR A 405 HIS A 406 MET A 519 ASP A 564 LEU A 565 PRO A 568 TRP A 578 THR A 579 ILE A 582 MET A 583 SER A 614 GLN A 615	None None 9VE A 801 (-3.8A) ZN A 699 ( 2.6A) 9VE A 801 (-4.7A) 9VE A 801 (-3.9A) None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 ( 4.0A) 9VE A 801 (-4.7A) 9VE A 801 (-3.2A)	0.23A	3g4lD-5ohjA: 53.5	3g4lD-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_D_ROFD904_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	3 / 3	ASN A 567 MET A 603 PHE A 618	9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.9A)	0.86A	3g4lD-5ohjA: 53.5	3g4lD-5ohjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 9	MET A 519 ASN A 567 ILE A 582 PHE A 586 MET A 603 GLN A 615 PHE A 618	9VE A 801 (-3.8A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.92A	3iakA-5ohjA: 51.5	3iakA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	8 / 9	TYR A 405 ASN A 567 ILE A 582 PHE A 586 MET A 603 GLN A 615 PHE A 618 ILE A 622	None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A) 9VE A 801 (-4.8A)	0.63A	3iakA-5ohjA: 51.5	3iakA-5ohjA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 9	TYR A 405 HIS A 406 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.63A	3jwqA-5ohjA: 39.2	3jwqA-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_B_VIAB901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 11	TYR A 405 HIS A 406 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.59A	3jwqB-5ohjA: 39.2 3jwqC-5ohjA: 39.1	3jwqB-5ohjA: 13.64 3jwqC-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 7	TYR A 405 HIS A 406 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.62A	3jwqC-5ohjA: 39.1	3jwqC-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_D_VIAD901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	6 / 11	TYR A 405 HIS A 406 PHE A 586 MET A 603 GLN A 615 PHE A 618	None None 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.72A	3jwqA-5ohjA: 39.2 3jwqD-5ohjA: 39.0	3jwqA-5ohjA: 13.64 3jwqD-5ohjA: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TVX_A_PNXA902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	9 / 9	TYR A 405 LEU A 565 ASN A 567 PRO A 568 THR A 579 ILE A 582 MET A 603 GLN A 615 PHE A 618	None 9VE A 801 (-4.7A) 9VE A 801 (-4.1A) 9VE A 801 (-3.9A) 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.60A	3tvxA-5ohjA: 54.7	3tvxA-5ohjA: 13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TVX_B_PNXB902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	7 / 7	TYR A 405 ASN A 567 ILE A 582 PHE A 586 MET A 603 GLN A 615 PHE A 618	None 9VE A 801 (-4.1A) 9VE A 801 (-4.1A) 9VE A 801 (-3.6A) 9VE A 801 (-3.6A) 9VE A 801 (-3.2A) 9VE A 801 (-3.9A)	0.58A	3tvxB-5ohjA: 54.4	3tvxB-5ohjA: 13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAQ_A_2GMA2001_2 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	4 / 6	ILE A 582 THR A 579 VAL A 453 ASP A 402	9VE A 801 (-4.1A) 9VE A 801 (-4.1A) None None	1.05A	4iaqA-5ohjA: undetectable	4iaqA-5ohjA: 11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDH_A_DAHA60_1 (PUTATIVE CYTOCHROME C)	5ohj	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	4 / 6	HIS A 400 VAL A 453 LEU A 475 GLN A 589	None None None 9VE A 801 (-3.4A)	1.41A	5xdhA-5ohjA: undetectable 5xdhC-5ohjA: 0.0	5xdhA-5ohjA: 18.48 5xdhC-5ohjA: 18.48

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1UHO_A_VDNA1000_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",6,"TYR A 405;HIS A 406;PHE A 586;GLN A 615;GLY A 617;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);None;9VE A 801 (-3.9A)","0.34A","1uhoA-5ohjA:36.4",null],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"HIS A 446;MET A 519;THR A 579;GLN A 615;PHE A 618"," ZN A 699 (-3.2A);9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","1.43A","1xlxA-5ohjA:52.6","1uhoA-5ohjA:12.96"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",12,"TYR A 405;HIS A 406;HIS A 450;MET A 519;LEU A 565;ASN A 567;THR A 579;ILE A 582;MET A 583;SER A 614;GLN A 615;PHE A 618","None;None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.36A","1xlxA-5ohjA:52.6","1xlxA-5ohjA:11.31"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",8,"HIS A 406;HIS A 450;MET A 519;MET A 583;PHE A 586;MET A 603;SER A 614;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.94A","1xlxB-5ohjA:52.6","1xlxA-5ohjA:11.31"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"HIS A 446;MET A 519;THR A 579;GLN A 615;PHE A 618"," ZN A 699 (-3.2A);9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","1.44A","1xlxB-5ohjA:52.6","1xlxB-5ohjA:11.31"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;HIS A 450;MET A 519;THR A 579;ILE A 582;MET A 583;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;None;9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.62A","1xlxB-5ohjA:52.6","1xlxB-5ohjA:11.31"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;ASP A 564;LEU A 565;PRO A 568;TYR A 575;TRP A 578;ILE A 582;PHE A 586;SER A 614;PHE A 618","None;None; ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.26A","1xmuA-5ohjA:53.3","1xlxB-5ohjA:11.31"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",8,"TYR A 405;LEU A 565;PRO A 568;TYR A 575;TRP A 578;ILE A 582;MET A 603;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.67A","1xmuA-5ohjA:53.3","1xmuA-5ohjA:undetectable"],["1XMU_A_ROFA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"MET A 519;ASN A 567;THR A 579;MET A 583;GLN A 615","9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.2A)","0.28A","1xmuA-5ohjA:53.3","1xmuA-5ohjA:undetectable"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;PRO A 568;TYR A 575;TRP A 578;ILE A 582;PHE A 586;SER A 614","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-4.7A)","0.30A","1xmuB-5ohjA:52.8","1xmuA-5ohjA:undetectable"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",10,"TYR A 405;MET A 519;ASP A 564;LEU A 565;PRO A 568;TYR A 575;TRP A 578;ILE A 582;MET A 603;SER A 614","None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-4.7A)","0.65A","1xmuB-5ohjA:52.8","1xmuB-5ohjA:undetectable"],["1XMU_B_ROFB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"ASN A 567;THR A 579;MET A 583;GLN A 615;PHE A 618","9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.15A","1xmuB-5ohjA:52.8","1xmuB-5ohjA:undetectable"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",6,"TYR A 405;ASP A 447;ILE A 582;MET A 583;PHE A 586;MET A 603","None; MG A 700 ( 2.7A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A)","1.41A","1xomA-5ohjA:52.6","1xmuB-5ohjA:undetectable"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;ILE A 582;MET A 583;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.59A","1xomA-5ohjA:52.6","1xomA-5ohjA:11.75"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;ILE A 582;MET A 583;PHE A 586;SER A 614;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.27A","1xomA-5ohjA:52.6","1xomA-5ohjA:11.75"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;LEU A 565;THR A 579;ILE A 582;MET A 583;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.58A","1xomB-5ohjA:52.1","1xomA-5ohjA:11.75"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;LEU A 565;THR A 579;ILE A 582;MET A 583;PHE A 586;SER A 614;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.29A","1xomB-5ohjA:52.1","1xomB-5ohjA:11.75"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"TYR A 405;HIS A 410;MET A 519;LEU A 565;THR A 579;GLN A 615;PHE A 618","None; ZN A 699 (-3.3A);9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","1.47A","1xomB-5ohjA:52.1","1xomB-5ohjA:11.75"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;PRO A 568;TYR A 575;THR A 579;ILE A 582;SER A 614;PHE A 618","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.25A","1xoqA-5ohjA:52.6","1xomB-5ohjA:11.75"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;LEU A 565;PRO A 568;TYR A 575;THR A 579;ILE A 582;MET A 603;SER A 614;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.56A","1xoqA-5ohjA:52.6","1xoqA-5ohjA:undetectable"],["1XOQ_A_ROFA502_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",3,"ASN A 567;TRP A 578;GLN A 615","9VE A 801 (-4.1A);None;9VE A 801 (-3.2A)","0.10A","1xoqA-5ohjA:52.6","1xoqA-5ohjA:undetectable"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;ASP A 564;LEU A 565;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;SER A 614;PHE A 618","None;None; ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.15A","1xoqB-5ohjA:51.9","1xoqA-5ohjA:undetectable"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;LEU A 565;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;MET A 603;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.55A","1xoqB-5ohjA:51.9","1xoqB-5ohjA:undetectable"],["1XOQ_B_ROFB501_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",3,"MET A 519;ASN A 567;GLN A 615","9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-3.2A)","0.31A","1xoqB-5ohjA:51.9","1xoqB-5ohjA:undetectable"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;MET A 583;PHE A 586;MET A 603;GLN A 615;PHE A 618;ILE A 622","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A);9VE A 801 (-4.8A)","0.61A","1xosA-5ohjA:52.1","1xoqB-5ohjA:undetectable"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"TYR A 405;HIS A 406;MET A 519;ASP A 564;MET A 583;PHE A 586;SER A 601","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);None","1.21A","1xosA-5ohjA:52.1","1xosA-5ohjA:11.31"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"TYR A 405;HIS A 410;MET A 519;LEU A 565;GLN A 615;PHE A 618;ILE A 622","None; ZN A 699 (-3.3A);9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A);9VE A 801 (-4.8A)","1.46A","1xosA-5ohjA:52.1","1xosA-5ohjA:11.31"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",12,"TYR A 405;HIS A 406;MET A 519;LEU A 565;ILE A 582;MET A 583;SER A 601;MET A 603;SER A 614;GLN A 615;PHE A 618;ILE A 622","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);None;9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A);9VE A 801 (-4.8A)","0.92A","1xotA-5ohjA:52.6","1xosA-5ohjA:11.31"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",8,"HIS A 406;MET A 519;LEU A 565;MET A 583;SER A 601;MET A 603;SER A 614;PHE A 618","None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 ( 4.0A);None;9VE A 801 (-3.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.91A","1xotB-5ohjA:52.6","1xotA-5ohjA:11.31"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;LEU A 565;ASN A 567;ILE A 582;MET A 583;SER A 601;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.64A","1xotB-5ohjA:52.6","1xotB-5ohjA:11.31"],["2H42_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;PHE A 586;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.37A","2h42A-5ohjA:36.2","1xotB-5ohjA:11.31"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;LEU A 565;PHE A 586;GLN A 615;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.56A","2h42C-5ohjA:35.9","2h42A-5ohjA:13.19"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;HIS A 406;LEU A 565;ILE A 582;GLU A 585;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-4.7A);9VE A 801 (-4.1A);None;9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","1.04A","2weyA-5ohjA:37.9","2h42C-5ohjA:13.19"],["3B2R_A_VDNA1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",6,"TYR A 405;HIS A 406;LEU A 565;PHE A 586;GLN A 615;PHE A 618","None;None;9VE A 801 (-4.7A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.68A","3b2rA-5ohjA:31.5","2weyA-5ohjA:11.47"],["3B2R_B_VDNB1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;LEU A 565;GLN A 615;PHE A 618","None;None;9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.69A","3b2rB-5ohjA:31.5","3b2rA-5ohjA:13.64"],["3CZV_A_AZMA263_1","CARBONIC ANHYDRASE 13;CARBONIC ANHYDRASE 13","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"HIS A 410;HIS A 446;PHE A 618;THR A 517;VAL A 623"," ZN A 699 (-3.3A); ZN A 699 (-3.2A);9VE A 801 (-3.9A);None;None","1.11A","3czvA-5ohjA:undetectable;3czvB-5ohjA:undetectable","3b2rB-5ohjA:13.64"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;ASN A 567;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;MET A 603;PHE A 618","None;9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.68A","3g4lA-5ohjA:51.7","3czvA-5ohjA:14.92;3czvB-5ohjA:14.92"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASN A 567;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;SER A 614;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-4.7A);9VE A 801 (-3.9A)","0.27A","3g4lA-5ohjA:51.7","3g4lA-5ohjA:undetectable"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;PRO A 568;TRP A 578;THR A 579;ILE A 582;MET A 583;PHE A 618","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.9A)","0.26A","3g4lB-5ohjA:52.0","3g4lA-5ohjA:undetectable"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;LEU A 565;PRO A 568;TRP A 578;THR A 579;ILE A 582;MET A 583;MET A 603;PHE A 618","None;None;9VE A 801 (-3.8A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.52A","3g4lB-5ohjA:52.0","3g4lB-5ohjA:undetectable"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",11,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;ASN A 567;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A)","0.26A","3g4lC-5ohjA:52.1","3g4lB-5ohjA:undetectable"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;LEU A 565;ASN A 567;PRO A 568;TYR A 575;TRP A 578;THR A 579;ILE A 582;MET A 603","None;9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.6A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A)","0.55A","3g4lC-5ohjA:52.1","3g4lC-5ohjA:undetectable"],["3G4L_C_ROFC903_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",3,"SER A 614;GLN A 615;PHE A 618","9VE A 801 (-4.7A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.18A","3g4lC-5ohjA:52.1","3g4lC-5ohjA:undetectable"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",12,"TYR A 405;HIS A 406;MET A 519;ASP A 564;LEU A 565;PRO A 568;TRP A 578;THR A 579;ILE A 582;MET A 583;SER A 614;GLN A 615","None;None;9VE A 801 (-3.8A); ZN A 699 ( 2.6A);9VE A 801 (-4.7A);9VE A 801 (-3.9A);None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 ( 4.0A);9VE A 801 (-4.7A);9VE A 801 (-3.2A)","0.23A","3g4lD-5ohjA:53.5","3g4lC-5ohjA:undetectable"],["3G4L_D_ROFD904_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",3,"ASN A 567;MET A 603;PHE A 618","9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.9A)","0.86A","3g4lD-5ohjA:53.5","3g4lD-5ohjA:undetectable"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"MET A 519;ASN A 567;ILE A 582;PHE A 586;MET A 603;GLN A 615;PHE A 618","9VE A 801 (-3.8A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.92A","3iakA-5ohjA:51.5","3g4lD-5ohjA:undetectable"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",8,"TYR A 405;ASN A 567;ILE A 582;PHE A 586;MET A 603;GLN A 615;PHE A 618;ILE A 622","None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A);9VE A 801 (-4.8A)","0.63A","3iakA-5ohjA:51.5","3iakA-5ohjA:11.75"],["3JWQ_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.63A","3jwqA-5ohjA:39.2","3iakA-5ohjA:11.75"],["3JWQ_B_VIAB901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.59A","3jwqB-5ohjA:39.2;3jwqC-5ohjA:39.1","3jwqA-5ohjA:13.64"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",5,"TYR A 405;HIS A 406;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.62A","3jwqC-5ohjA:39.1","3jwqB-5ohjA:13.64;3jwqC-5ohjA:13.64"],["3JWQ_D_VIAD901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",6,"TYR A 405;HIS A 406;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;None;9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.72A","3jwqA-5ohjA:39.2;3jwqD-5ohjA:39.0","3jwqC-5ohjA:13.64"],["3TVX_A_PNXA902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",9,"TYR A 405;LEU A 565;ASN A 567;PRO A 568;THR A 579;ILE A 582;MET A 603;GLN A 615;PHE A 618","None;9VE A 801 (-4.7A);9VE A 801 (-4.1A);9VE A 801 (-3.9A);9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.60A","3tvxA-5ohjA:54.7","3jwqA-5ohjA:13.64;3jwqD-5ohjA:13.64"],["3TVX_B_PNXB902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",7,"TYR A 405;ASN A 567;ILE A 582;PHE A 586;MET A 603;GLN A 615;PHE A 618","None;9VE A 801 (-4.1A);9VE A 801 (-4.1A);9VE A 801 (-3.6A);9VE A 801 (-3.6A);9VE A 801 (-3.2A);9VE A 801 (-3.9A)","0.58A","3tvxB-5ohjA:54.4","3tvxA-5ohjA:13.25"],["4IAQ_A_2GMA2001_2","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",4,"ILE A 582;THR A 579;VAL A 453;ASP A 402","9VE A 801 (-4.1A);9VE A 801 (-4.1A);None;None","1.05A","4iaqA-5ohjA:undetectable","3tvxB-5ohjA:13.25"],["5XDH_A_DAHA60_1","PUTATIVE CYTOCHROME C;PUTATIVE CYTOCHROME C","5ohj","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","Homo sapiens",4,"HIS A 400;VAL A 453;LEU A 475;GLN A 589","None;None;None;9VE A 801 (-3.4A)","1.41A","5xdhA-5ohjA:undetectable;5xdhC-5ohjA:0.0","4iaqA-5ohjA:11.66"]]